MDGLNasdaq United States
Market cap
$11.784 B
$510.04 -0.06%
Close of 7 Aug 2026
Revenue
$180.1M
#2330 by revenue
Earnings
-$288.3M
Loss-making
Shares outstanding
23,104,126
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Madrigal Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.